X Bioscience PCL Statistics

Total Valuation

BKK:XBIO has a market cap or net worth of THB 356.64 million. The enterprise value is 983.40 million.

Market Cap	356.64M
Enterprise Value	983.40M

Important Dates

The last earnings date was Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BKK:XBIO has 2.10 billion shares outstanding. The number of shares has increased by 64.88% in one year.

Current Share Class	2.10B
Shares Outstanding	2.10B
Shares Change (YoY)	+64.88%
Shares Change (QoQ)	+14.20%
Owned by Insiders (%)	17.54%
Owned by Institutions (%)	n/a
Float	1.68B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.17
PB Ratio	0.44
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.57
EV / Sales	3.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.49

Financial Position

The company has a current ratio of 0.23, with a Debt / Equity ratio of 0.40.

Current Ratio	0.23
Quick Ratio	0.08
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	-4.10
Interest Coverage	-8.98

Financial Efficiency

Return on equity (ROE) is -61.84% and return on invested capital (ROIC) is -20.70%.

Return on Equity (ROE)	-61.84%
Return on Assets (ROA)	-16.86%
Return on Invested Capital (ROIC)	-20.70%
Return on Capital Employed (ROCE)	-30.03%
Revenue Per Employee	766,548
Profits Per Employee	-690,916
Employee Count	399
Asset Turnover	0.29
Inventory Turnover	19.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.44% in the last 52 weeks. The beta is 0.78, so BKK:XBIO's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-73.44%
50-Day Moving Average	0.13
200-Day Moving Average	0.43
Relative Strength Index (RSI)	57.15
Average Volume (20 Days)	17,017,670

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BKK:XBIO had revenue of THB 305.85 million and -275.68 million in losses. Loss per share was -0.18.

Revenue	305.85M
Gross Profit	114.53M
Operating Income	-280.96M
Pretax Income	-307.33M
Net Income	-275.68M
EBITDA	-239.59M
EBIT	-280.96M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 3.99 million in cash and 322.60 million in debt, giving a net cash position of -318.61 million or -0.15 per share.

Cash & Cash Equivalents	3.99M
Total Debt	322.60M
Net Cash	-318.61M
Net Cash Per Share	-0.15
Equity (Book Value)	803.52M
Book Value Per Share	0.24
Working Capital	-328.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -50.52 million and capital expenditures -28.19 million, giving a free cash flow of -78.71 million.

Operating Cash Flow	-50.52M
Capital Expenditures	-28.19M
Free Cash Flow	-78.71M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 37.45%, with operating and profit margins of -91.86% and -90.13%.

Gross Margin	37.45%
Operating Margin	-91.86%
Pretax Margin	-100.48%
Profit Margin	-90.13%
EBITDA Margin	-78.33%
EBIT Margin	-91.86%
FCF Margin	n/a

Dividends & Yields

BKK:XBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-64.88%
Shareholder Yield	-64.88%
Earnings Yield	-77.30%
FCF Yield	-22.07%

Stock Splits

The last stock split was on May 5, 2021. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	May 5, 2021
Split Type	Reverse
Split Ratio	0.0666666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a